Regulatory Risk Management in Nanotechnology: Proactive Steps to Take Now for Security in the Future
September 27, 2007
Foley is proud to introduce its Nanotechnology Web conference series, The Business of Nanotech. This series is designed to keep participants up-to-date on the latest developments in the field of nanotechnology and the impact of those developments across industries.
In this, our inaugural program, we discussed Regulatory Risk Management in Nanotechnology: Proactive Steps to Take Now for Security in the Future. Specific topics included:
- The future prospects for U.S. Environmental Protection Agency (EPA) and U.S. Food and Drug Administration (FDA) regulatory activity
- Developments in self-regulatory initiatives involving industry and consumer groups
- The effects of activist opposition on the regulatory process
- Potential paths forward for the regulatory process
- Regulatory initiatives in key international markets
Speakers
- Val Giddings, President and CEO, PrometheusAB
- Mark Mansour, Partner, Foley
- Michael R. Pontrelli, Partner, Foley
People
Related Insights
July 23, 2025
Events
Healthcare Supply Chain Compliance Challenges: Vendor Management, Contract Negotiation, Tariff Impact
Foley partner Monica Chmielewski, vice chair of the firm’s Health Care Practice Group, is speaking in Strafford’s upcoming webinar titled “Healthcare Supply Chain Compliance Challenges: Vendor Management, Contract Negotiation, Tariff Impact” on July 23.
September 30, 2025
Events
FDA Regulation of AI-Enabled Medical Devices
Foley partner Kyle Faget, co-chair of the firm’s Medical Devices Area of Focus, is speaking at the American Bar Association Health Law Section’s Healthcare Delivery & Innovation Conference on September 30.
July 10, 2025
Foley Viewpoints
One Big Beautiful Bill Act Permanently Increases the Lifetime Estate, Gift and GST Tax Exclusion
On July 4, 2025, President Trump signed into law the One Big Beautiful Bill Act (OBBBA). The OBBBA extended and may permanent many key…